Simbrinza 1 % (Brinzolamide SUSPENSION) 1 %

SIMBRINZA 1% is an ophthalmic suspension containing brinzolamide 1% for eye care. It is commonly used to reduce intraocular pressure in conditions like glaucoma. This medication is manufactured by Novartis Pharmaceuticals Canada Inc.

Strength

1 %

Pack Size

10ML

Manufacturer / TM Owner

NOVARTIS PHARMACEUTICALS CANADA INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

SIMBRINZA 1% is primarily used to lower intraocular pressure in the eyes. It is often prescribed for conditions such as glaucoma, where managing eye pressure is crucial. The active ingredient, brinzolamide, works to reduce the production of aqueous humor, helping to maintain healthy eye pressure levels. People often ask, 'What is SIMBRINZA 1% used for?' and the answer is primarily for managing intraocular pressure.

Side Effects

Common effects of SIMBRINZA 1% may include temporary blurred vision, eye redness, or a stinging sensation upon application. These effects are usually mild and short-lived. Some users may also experience a bitter taste following administration, which is a common side effect of brinzolamide ophthalmic suspensions.

Precautions & Warnings

SIMBRINZA 1% should be used with caution in individuals with known allergies to brinzolamide or other carbonic anhydrase inhibitors. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Always store the suspension at room temperature and keep it out of reach of children.

Avoid Interactions

SIMBRINZA 1% may interact with other medications, particularly those that affect eye pressure or have similar active ingredients. It is advisable to inform your healthcare provider about all medications you are currently taking. Avoid using SIMBRINZA 1% with other eye drops unless directed by a healthcare professional.

Frequently Asked Questions

SIMBRINZA 1% is used to reduce intraocular pressure in conditions like glaucoma.

SIMBRINZA 1% is typically administered as eye drops. Follow the instructions provided by your healthcare professional.

Common side effects may include temporary blurred vision, eye redness, and a stinging sensation.

It is advisable to consult a healthcare professional before using SIMBRINZA 1% with other eye drops.

SIMBRINZA 1% should be stored at room temperature and kept out of reach of children.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.